Filter
1730
Featured
163
450
Language
Document type
892
316
268
80
73
45
23
16
11
3
2
1
Countries
84
57
46
37
31
31
30
29
28
27
27
25
25
24
21
21
20
18
18
17
17
16
16
16
16
15
14
14
13
13
13
13
11
11
11
10
10
10
10
10
9
9
8
8
7
7
7
7
6
6
6
6
6
6
5
5
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
634
179
117
111
51
24
15
2
Toolboxes
146
124
121
116
60
59
50
47
45
44
39
39
38
38
37
25
24
11
9
7
7
6
6
Monitoring and evaluation framework
recommended
COVID‑19 strategic preparedness and response
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i
...
These guidelines present evidence-based recommendations and best practice statements on use of medically important antimicrobials in food-producing animals, based on the WHO list of critically important antimicrobials for human medicine (WHO CIA List). These guidelines aim primarily to help preserve
...
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.
Division of Tuberculosis Elimination.
Namibia guideline for submission of applications for registration of pharmaceuticals for human use in common technical document format.
Policy Brief | April 2015 | This brief accompanies the data sheet, Addressing Risk Factors for Noncommunicable Diseases Among Young People in Africa: Key to Prevention and Sustainable Development, and its data appendix, which provide all available country-specific data on four key NCD risk factors a
...
Overcoming Barriers to TB Control
Training Curriculum
August 2011
Key populations brief.
4–15 February 2013
